Stay updated on Fruquintinib in 2nd-line Biliary AdenoCa Clinical Trial
Sign up to get notified when there's something new on the Fruquintinib in 2nd-line Biliary AdenoCa Clinical Trial page.

Latest updates to the Fruquintinib in 2nd-line Biliary AdenoCa Clinical Trial page
- Check7 days agoChange DetectedA 403 Forbidden error now displays on the study page, replacing the former content with an error screen. This blocks access to the study details and related information.SummaryDifference18%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe site revision indicator was updated from Revision: v3.6.5 to Revision: v3.6.6, signaling a deployment or update to the page. This change does not alter the study content or how the page presents information to users.SummaryDifference0.1%

- Check49 days agoChange DetectedThe page now shows a new revision number (v3.6.5) replacing the previous revision (v3.6.4). This is a minor maintenance update and does not modify study data or displayed details.SummaryDifference0.0%

- Check64 days agoChange DetectedRevision label updated from v3.6.3 to v3.6.4, indicating a new build of the site's template. The change reflects internal updates to the page framework and does not modify the trial details shown to users.SummaryDifference0.0%

- Check85 days agoChange DetectedThe page's revision tag was updated from v3.6.2 to v3.6.3, indicating a new version of the study page, likely due to editorial or QC updates.SummaryDifference0.0%

- Check93 days agoChange DetectedRevision metadata updated from v3.6.0 to v3.6.2, indicating a newer version deployed for the page. This appears to be a backend/template update rather than a change to the study information.SummaryDifference0.0%

Stay in the know with updates to Fruquintinib in 2nd-line Biliary AdenoCa Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fruquintinib in 2nd-line Biliary AdenoCa Clinical Trial page.